Prognostic factors for survival after enucleation for choroidal and ciliary body melanomas

Acta Ophthalmologica Scandinavica

Volumn 82, Issue 5, 2004, Pages 517-525

  Isager, Peter ^a   Ehlers, Niels ^a   Overgaard, Jens ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Melanoma; Ocular; Prognosis; Survival; Uvea

Indexed keywords

ADULT; AGE; AGED; ARTICLE; CANCER MORTALITY; CANCER SURVIVAL; CAUSE OF DEATH; CELL TYPE; CHOROID MELANOMA; CILIARY BODY MELANOMA; CLINICAL FEATURE; CONTROLLED STUDY; ENUCLEATION; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; NONBIOLOGICAL MODEL; PRIORITY JOURNAL; PROGNOSIS; RISK ASSESSMENT; SEX DIFFERENCE; SPINDLE CELL; TREATMENT OUTCOME; TUMOR GROWTH; TUMOR LOCALIZATION; TUMOR VOLUME; UVEA MELANOMA; VITAL STATISTICS;

ADULT; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; CHOROID NEOPLASMS; CILIARY BODY; EYE ENUCLEATION; FEMALE; HUMANS; MALE; MELANOMA; MIDDLE AGED; NEOPLASM INVASIVENESS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; SEX DISTRIBUTION; SURVIVAL ANALYSIS; UVEAL NEOPLASMS;

EID: 6344237272     PISSN: 13953907     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0420.2004.00330.x     Document Type: Article

References (61)

1. Affeldt JC, Minckler DS, Azen SP & Yeh L (1980): Prognosis in uveal melanoma with extrascleral extension. Arch Ophthalmol 98: 1975-1979.
2. Augsburger JJ & Gamel JW (1990): Clinical prognostic factors in patients with posterior uveal malignant melanoma. Cancer 66: 1596-1600.
3. Augsburger JJ, Shields JA, Folberg R, Lang W, O'Hara BJ & Claricci JD (1985): Fine-needle aspiration biopsy in the diagnosis of intraocular cancer. Cytologic-histologic correlations. Ophthalmology 92: 39-49.
4. Baker JR (1958): The Reactions of Fixatives with Tissues and Cells: Methods of Research. Principles of Biological Microtechnique. A Study of Fixation and Dyeing. London: Methuen & Co Ltd.
5. Bartsch DU, Weinreb RN, Zinser G & Freeman WR (1995): Confocal scanning infrared laser ophthalmoscopy for indocyanine green angiography. Am J Ophthalmol 120: 642-651.
6. Callender GR (1931): Malignant melanotic tumours of the eye: a study of histologic types in 111 cases. Trans Am Acad Ophthalmol Otolaryngol 36: 131-142.
7. Char DH, Kroll SM, Miller T, Castro J & Quivey J (1996): Irradiated uveal melanomas: cytopathologic correlation with prognosis. Am J Ophthalmol 122: 509-513.
8. Char DH, Kroll SM, Stoloff A, Kaleta-Michaels S, Crawford JB, Miller TR, Howes EL Jr & Ljung BM (1991): Cytomorphometry of uveal melanoma. Comparison of fine-needle aspiration biopsy samples with histologic sections. Anal Quant Cytol Histol 13: 293-299.
9. Char DH, Stone RD, Irvine AR, Crawford JB, Hilton GF, Lorin LI & Schwartz A (1980): Diagnostic modalities in choroidal melanoma. Am J Ophthalmol 89: 223-230.
10. Coleman K, Baak JP, van Diest PJ & Mullaney J (1996): Prognostic value of morphometric features and the Callender classification in uveal melanomas. Ophthalmology 103: 1634-1641.
11. Coleman K, Baak JP, Van Diest P, Mullaney J, Farrell M & Fenton M (1993): Prognostic factors following enucleation of 111 uveal melanomas. Br J Ophthalmol 77: 688-692.
12. Collaborative Ocular Melanoma Study (1998): The Collaborative Ocular Melanoma Study (COMS) randomized trial of pre-enucleation radiation of large choroidal melanoma. II: Initial mortality findings. COMS Report 10. Am J Ophthalmol 125: 779-796.
13. Crowley NJ & Seigler HF (1990): Late recurrence of malignant melanoma. Analysis of 168 patients. Ann Surg 212: 173-177.
14. Davidorf FH & Lang JR (1975): The natural history of malignant melanoma of the choroid: small versus large tumours. Trans Am Acad Ophthalmol Otolaryngol 79: 310-320.
15. de la Cruz POJr, Specht CS & McLean IW (1990): Lymphocytic infiltration in uveal malignant melanoma. Cancer 65: 112-115.
16. Diener-West M, Earle JD, Fine SL, Hawkins BS, Moy CS, Reynolds SM, Schachat AP & Straatsma BR (2001): The COMS randomized trial of iodine 125 brachytherapy for choroidal melanoma. III: Initial mortality findings. COMS Report 18. Arch Ophthalmol 119: 969-982.
17. Folberg R, Augsburger JJ, Gamel JW, Shields JA & Lang WR (1985): Fine-needle aspirates of uveal melanomas and prognosis. Am J Ophthalmol 100: 654-657.
18. Folberg R, Mehaffey M, Gardner LM, Meyer M, Rummelt V & Pe'er J (1997): The microcirculation of choroidal and ciliary body melanomas. Eye 11: 227-238.
19. Folberg R, Pe'er J, Gruman LM et al. (1992): The morphologic characteristics of tumour blood vessels as a marker of tumour progression in primary human uveal melanoma: a matched case-control study. Hum Pathol 23: 1298-1305.
20. Folberg R, Rummelt V, Parys-Van Ginderdeuren R, Hwang T, Woolson RF, Pe'er J & Gruman LM (1993): The prognostic value of tumour blood vessel morphology in primary uveal melanoma. Ophthalmology 100 1389-1398.
21. Foss AJ, Alexander RA, Jefferies LW, Hungerford JL, Harris AL & Lightman S (1996): Microvessel count predicts survival in uveal melanoma. Cancer Res 56: 2900-2903.
22. Gamel JW, McCurdy JB & McLean IW (1992): A comparison of prognostic covariates for uveal melanoma. Invest Ophthalmol Vis Sci 33 1919-1922.
23. Isager P (2004): Ocular malignant melanoma. Epidemiological and clinical aspects. PhD thesis. University of Århus.
24. Jensen OA (1963): Malignant melanomas of the uvea in Denmark 1943-52. A clinical, histopathological, and prognostic study. Thesis. University of Copenhagen. Acta Ophthalmol (Copenh) 41 (75): 1-220.
25. Jensen OA (1982): Malignant melanomas of the human uvea: 25-year follow-up of cases in Denmark, 1943-52. Acta Ophthalmol (Copenh) 60: 161-182.
26. Kidd MN, Lyness RW, Patterson CC, Johnston PB & Archer DB (1986): Prognostic factors in malignant melanoma of the choroid: a retrospective survey of cases occurring in Northern Ireland between 1965 and 1980. Trans Ophthalmol Soc U K 105: 114-121.
27. Kleineidam M, Guthoff R & Bentzen SM (1993): Rates of local control, metastasis and overall survival in patients with posterior uveal melanomas treated with ruthenium-106 plaques. Radiother Oncol 28: 148-156.
28. Kroll S, Char DH, Quivey J & Castro J (1998): A comparison of cause-specific melanoma mortality and all-cause mortality in survival analyses after radiation treatment for uveal melanoma. Ophthalmology 105: 2035-2045.
29. Kujala E, Mäkitie T & Kivelä T (2003): Very longterm prognosis of patients with malignant uveal melanoma. Invest Ophthalmol Vis Sci 44: 4651-4659.
30. Lattman J, Kroll S, Char DH, Ghazvini S, Frigillana H, O'Brien JM & Elbakri HR (1995): Cell cycling and prognosis in uveal melanoma. Clin Cancer Res 1: 41-47.
31. Makitie T, Summanen P, Tarkkanen A & Kivelä T (1999): Microvascular density in predicting survival of patients with choroidal and ciliary body melanoma. Invest Ophthalmol Vis Sci 40: 2471-2480.
32. McLean IW, Ainbinder DJ, Gamel JW & McCurdy JB (1995): Choroidal-ciliary body melanoma. A multivariate survival analysis of tumour location. Ophthalmology 102: 1060-1064.
33. McLean IW, Foster WD & Zimmerman LE (1982): Uveal melanoma: location, size, cell type and enucleation as risk factors in metastasis. Hum Pathol 13: 123-132.
34. McLean IW, Foster WD, Zimmerman LE & Gamel JW (1983): Modifications of Callender's classification of uveal melanoma at the Armed Forces Institute of Pathology. Am J Ophthalmol 96: 502-509.
35. Mueller AJ, Bartsch DU, Folberg R et al. (1998): Imaging the microvasculature of choroidal melanomas with confocal indocyanine green scanning laser ophthalmoscopy. Arch Ophthalmol 116: 31-39.
36. Naus NC, Verhoeven AC, van Drunen E, Slater R, Mooy CM, Paridaens DA, Luyten GP & de Klein A (2002): Detection of genetic prognostic markers in uveal melanoma biopsies using fluorescence in situ hybridization. Clin Cancer Res 8: 534-539.
37. Nicholson DH, Frazier-Byrne S, Chin MT, Schiffman J, Hughes JR & Novinski EK (1985): Echographic and histologic tumour height measurements in uveal melanoma. Am J Ophthalmol 100: 454-457.
38. Packard RB (1980): Pattern of mortality in choroidal malignant melanoma. Br J Ophthalmol 64: 565-575.
39. Packard RB (1983): In malignant choroidal melanoma will a delay in radical treatment influence prognosis? Trans Ophthalmol Soc U K 103: 49-53.
40. Patel KA, Edmondson ND, Talbot F, Parsons MA, Rennie IG & Sisley K (2001): Prediction of prognosis in patients with uveal melanoma using fluorescence in situ hybridization. Br J Ophthalmol 85: 1440-1444.
41. Pe'er J, Rummelt V, Mawn L, Hwang T, Woolson RF & Folberg R (1994): Mean of the 10 largest nucleoli, microcirculation architecture, and prognosis of ciliochoroidal melanomas. Ophthalmology 101: 1227-1235.
42. Polivogianis L, Seddon JM, Glynn RJ, Gragoudas ES & Albert DM (1988): Comparison of transillumination and histologic slide measurements of tumour diameter in uveal melanoma. Ophthalmology 95: 1576-1582.
43. Prescher G, Bornfeld N, Hirche H, Horsthemke B, Jockel KH & Becher R (1996): Prognostic implications of monosomy 3 in uveal melanoma. Lancet 347: 1222-1225.
44. Raivio I (1977): Uveal melanoma in Finland. Thesis. University of Helsinki. Acta Ophthalmol (Copenh) 55 (133): 1-64.
45. Regan S, Judge HE, Gragoudas ES & Egan KM (1999): Iris colour as a prognostic factor in ocular melanoma. Arch Ophthalmol 117: 811-814.
46. Rummelt V, Folberg R, Woolson RF, Hwang T & Pe'er J (1995): Relation between the microcirculation architecture and the aggressive behaviour of ciliary body melanomas. Ophthalmology 102: 844-851.
47. Scholes AG, Damato BE, Nunn J, Hiscott P, Grierson I & Field JK (2003): Monosomy 3 in uveal melanoma: correlation with clinical and histologic predictors of survival. Invest Ophthalmol Vis Sci 44: 1008-1011.
48. Seddon JM, Albert DM, Lavin PT & Robinson N (1983): A prognostic factor study of disease-free interval and survival following enucleation for uveal melanoma. Arch Ophthalmol 101: 1894-1899.
49. Seregard S & Kock E (1995): Prognostic indicators following enucleation for posterior uveal melanoma. A multivariate analysis of long-term survival with minimized loss to follow-up. Acta Ophthalmol Scand 73: 340-344.
50. Seregard S, Oskarsson M & Spangberg B (1996): PC-10 as a predictor of prognosis after antigen retrieval in posterior uveal melanoma. Invest Ophthalmol Vis Sci 37: 1451-1458.
51. Seregard S, Spangberg B, Juul C & Oskarsson M (1998): Prognostic accuracy of the mean of the largest nucleoli, vascular patterns and PC-10 in posterior uveal melanoma. Ophthalmology 105: 485-491.
52. Servodidio CA & Abramson DH (1992): Presenting signs and symptoms of choroidal melanoma: what do they mean? Ann Ophthalmol 24 190-194.
53. Shammas HF & Blodi FC (1977): Prognostic factors in choroidal and ciliary body melanomas. Arch Ophthalmol 95: 63-69.
54. Shields JA, Augsburger JJ, Donoso LA, Bernardino VB Jr & Portenar M (1985): Hepatic metastasis and orbital recurrence of uveal melanoma after 42 years. Am J Ophthalmol 100: 666-668.
55. Shields CL, Shields JA, Kiratli H, De Potter P & Cater JR (1995): Risk factors for growth and metastasis of small choroidal melanocytic lesions. Ophthalmology 102: 1351-1361.
56. Singh AD, Shields CL & Shields JA (2001): Prognostic factors in uveal melanoma. Melanoma Res 11: 255-263.
57. Sisley K, Rennie IG, Parsons MA, Jacques R, Hammond DW, Bell SM, Potter AM & Rees RC (1997): Abnormalities of chromosomes 3 and 8 in posterior uveal melanoma correlate with prognosis. Genes Chromosomes Cancer 19: 22-28.
58. Sorensen FB, Gamel JW, Jensen OA, Ladekarl M & McCurdy J (1993): Prognostic value of nucleolar size and size pleomorphism in choroidal melanomas. APMIS 101: 358-368.
59. Storm HH (1984): Validity of Death Certificates for Cancer Patients in Denmark 1977. Copenhagen Danish Cancer Registry.
60. Thomas JV, Green WR & Maumenee AE (1979): Small choroidal melanomas. A longterm follow-up study. Arch Ophthalmol 97: 861-864.
61. Umlas J, Diener-West M, Robinson NL, Green WR, Grossniklaus HE & Albert DM (1997): Comparison of transillumination and histologic slide measurements of choroidal melanoma. Arch Ophthalmol 115: 474-477.